950220 — Neoimmunetech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Neoimmunetech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	65.5	130	92.4	53.6	23.7
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	0.037
Prepaid Expenses
Total Other Current Assets
Total Current Assets	74.1	141	93.1	56	26.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.73	7.64	7.41	6.01	4.61
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	87.9	158	110	70.2	44.5
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.27	17.2	12.9	9.99	14.1
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	10.5	21.1	15.9	12.1	16.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	77.4	137	94.4	58.1	28.3
Total Liabilities & Shareholders' Equity	87.9	158	110	70.2	44.5
Total Common Shares Outstanding